| R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions. PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.
Authors: Pandolfi A, Stanley R, Yu Y, Bartholdy B, Pendurti G, Gritsman K, Boultwood J, Chernoff J, Verma A, Steidl U
Blood, 2015;126(9):1118-27.
Species: Human
Sample Type: Whole Cells
miR-9 is a tumor suppressor in pediatric AML with t(8;21).
Authors: Emmrich, S, Katsman-Kuipers, J E, Henke, K, Khatib, M E, Jammal, R, Engeland, F, Dasci, F, Zwaan, C M, den Boer, M L, Verboon, L, Stary, J, Baruchel, A, de Haas, V, Danen-van Oorschot, A A, Fornerod, M, Pieters, R, Reinhardt, D, Klusmann, J H, van den Heuvel-Eibrink, M M
Leukemia, 2014;28(5):1022-32.
Species: Human
Sample Type: whole cells
Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models.
Authors: Portwood S, Lal D, Hsu Y, Vargas R, Johnson M, Wetzler M, Hart C, Wang E
Clin Cancer Res, 2013;19(23):6506-19.
Species: Human
Sample Type: Whole Cells
Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models.
Authors: Zibara K, Hamdan R, Dib L
PLoS ONE, 2012;7(7):e40140.
Species: Human
Sample Type: Whole Cells
Differential requirements for hematopoietic commitment between human and rhesus embryonic stem cells.
Authors: Rajesh</LastName><ForeNam D</Initial, Rajesh D, Chinnasamy N, Mitalipov SM, Wolf DP, Slukvin I, Thomson JA, Shaaban AF
Stem Cells, 2007;25(2):490-9.
Species: Human
Sample Type: Whole Cells
|
